Brief: Renovorx Announces Pricing Of $12.1 Million Underwritten Public Offering Of Common Stock
Feb 6 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES PRICING OF $12.1 MILLION UNDERWRITTEN
PUBLIC
OFFERING OF COMMON STOCK
* RENOVORX INC - PRICING PUBLIC OFFERING OF 11,523,810
SHARES OF
ITS COMMON STOCK AT A PRICE TO PUBLIC OF $1.05 PER SHARE
Source text: ID:nBwbNfb11a
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies